Popular Trials
Cell Therapy
NT-501 ECT Implant for Glaucoma
Recruiting0 awardsPhase 2
Palo Alto, California
This trial tests a new eye implant called NT-501 for people with glaucoma. The implant releases medicine directly into the eye to help protect it from damage. It aims to help those who may not respond well to usual treatments. An earlier version of this implant has been used to help manage glaucoma in patients who did not benefit from other treatments.
CAR T-cell Therapy
TCRγδ T Cells + Blinatumomab for Blood Cancers
Recruiting1 awardPhase 2
Memphis, Tennessee
This trial is examining a treatment therapy that could reduce toxicity and relapse while promoting rapid immune reconstitution with limited serious graft-versus-host-disease (GVHD) for patients with hematologic malignancies.
Breast Implant
MemoryGel Breast Implants for Breast Reconstruction
Recruiting1 award
Montgomery, Alabama
This trial is testing new, larger breast implants for patients needing breast reconstruction after mastectomy or revision surgery. The implants are designed to provide a fuller, more natural look. The new implants allow for a significant improvement in shaping the final contour of the breast.
Behavioural Intervention
Stroboscopic Vision Training for Softball Performance
Recruiting1 award3 criteria
Lubbock, Texas
This trial is testing if stroboscopic vision goggles, which flicker to remove visual information for a brief moment, can enhance visual performance during a softball season for high school girls.
Popular Filters
Trials With No Placebo
Procedure
NPWT vs Conventional Dressings for Hip Surgery Recovery
Recruiting1 awardPhase 1
Chicago, Illinois
This trial will compare the rate of wound complications, infection, and reoperation following revision total hip arthroplasty when treated with negative pressure wound therapy (NPWT) versus sterile dressings.
Stem Cell Therapy
Stem Cell Therapy for Age-Related Macular Degeneration
Recruiting1 awardPhase 1
Los Angeles, California
This trial is for adults 50+ who are losing their vision due to dry age-related macular degeneration. A new treatment, ASP7317, which is a specially created type of cell derived from human stem cells, will be injected into the macula of the eye in an effort to slow or reverse atrophy.
Orthopedic Implant
ATTUNE Revision Knee System for Total Knee Replacement
Recruiting1 award
San Diego, California
This trial studies the ATTUNE® Revision knee replacement system in patients aged 22-80 with complex knee issues. The system uses customizable parts to improve knee stability and function. The goal is to evaluate how well this system works over time. The ATTUNE Knee System has shown excellent clinical and radiographical outcomes, with a high survival rate.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.